Come up with a name for your new list and we'll add to it:
VenatoRx Pharmaceuticals raised a round of funding on January 04, 2018. Investors include
U.S. Department of Defense.
VenatoRx Pharmaceuticals is a disease-focused pharmaceutical company dedicated to the discovery and development of novel anti-infective agents. The company's goal is to identify and progress into clin…